Metabolic biomarkers in irritable bowel syndrome diagnosis
Authors:
- Omid VakiliOVOmid Vakili
- Peyman Adibi SedehPSPeyman Adibi Sedeh
- Morteza PourfarzamMPMorteza Pourfarzam
- 29 May 2024
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 560
Abstract
No abstract availableKeywords
This publication has 164 references indexed in Scilit:
- microRNAs in female infertility: An overviewCell Biochemistry and Function, 2021
- Diagnosis and Treatment of Irritable Bowel SyndromeJAMA, 2021
- Choline and dimethylglycine produce superoxide/hydrogen peroxide from the electron transport chain in liver mitochondriaFEBS Letters, 2016
- Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening StrategiesJAMA, 2016
- Screening for Colorectal CancerJAMA, 2016
- Irritable Bowel SyndromeJAMA, 2015
- HILIC‐MS‐based shotgun metabolomic profiling of maternal urine at 9–23 weeks of gestation – establishing the baseline changes in the maternal metabolomeBiomedical Chromatography, 2014
- Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry‐based metabolomicsJournal of Applied Toxicology, 2011
- Challenges and opportunities of metabolomicsJournal of Cellular Physiology, 2011
- Salivary proteomic and genomic biomarkers for primary Sjögren's syndromeArthritis & Rheumatism, 2007